Tag: Wang

BEIJING, CHINA, June 19, 2025 (GLOBE NEWSWIRE) -- This year, the Beijing International Film Festival made its Australian debut, hosting a special promotional event on June 13 during the 72nd Sydney International Film Festival, marking a fresh encounter between Chinese cinematic culture and audiences in the Southern Hemisphere. Australia is a land that has not only nurtured a rich and unique geographical landscape but has also produced diverse masterpieces that have made their mark on the international film scene, such as "Memoir of a Snail," "Hacksaw Ridge," "Mad Max: Fury Road," and "Moulin Rouge." As the country's most representative film event, the Sydney International Film Festival brings together outstanding films and creators from around the world, allowing this harbor city to showcase its unique cultural charm through the interplay of light and shadow.

New Taipei City, Taiwan, June 18, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia, today announced the closing of its initial public offering (the “Offering”) of 2,666,667 ordinary shares (the “Ordinary Shares”) at a public offering price of $7.5 per share for aggregate gross proceeds of approximately $20 million, before deducting underwriting discounts and other offering expenses. The Ordinary Shares commenced trading on Nasdaq Global Market on June 17, 2025, under the ticker symbol “MENS”. The Offering closed on June 18, 2025.

New Taipei City, Taiwan, June 16, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (the “Company”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia, today announced the pricing of its initial public offering (the “Offering”) of 2,666,667 ordinary shares (the “Ordinary Shares”) at a public offering price of $7.50 per share. The Company expects to receive aggregate gross proceeds of approximately $20 million, before deducting underwriting discounts and other offering expenses. The Ordinary Shares have been approved for listing on the Nasdaq Global Market and are expected to commence trading on June 17, 2025 under the ticker symbol “MENS”. The Offering is expected to close on June 18, 2025, subject to the satisfaction of customary closing conditions. In addition, the Company has granted the underwriters an option (the "Over-Allotment Option"), within 45 days from the date of the final prospectus, to purchase up to an additional 400,000 Ordinary Shares at the public offering price, less underwriting discounts, to cover the Over-Allotment Option, if any.

VICTORIA, Seychelles, June 16, 2025 (GLOBE NEWSWIRE) -- Bitget, bursa mata wang kripto dan syarikat Web3 terkemuka telah mengumumkan satu siri ciri naik taraf yang berkuasa termasuk pesanan had, TP/SL kedudukan pintar dan amaran token baharu untuk platform Onchain mereka. Semua ini bertujuan untuk memberikan pengguna lebih ketepatan, kawalan dan cerapan masa nyata dalam perdagangan onchain.